Top 50 Life Science Startup Investors in France in January 2025

Investor	Life Science France investments
Bpifrance	12
Kurma Partners	8
Omnes Capital	6
Seventure Partners	5
Idinvest Partners	4
Paca Investissement	4
Sofinnova Partners	3
AdBio partners	3
Karista	3
Blue Horizon Corporation	3
Boehringer Ingelheim Venture Fund	3
Galia Gestion	3
IRDI SORIDEC Gestion	2
Air Street Capital	2
Beyond Impact	2
JDRF T1D Fund	2
XAnge	2
Kinled Holding	2
Heartcore Capital	2
Social Starts	2
Thia Ventures	2
Advent Life Sciences	2
Partech	2
Sylvain Zimmer	2
Horizons Ventures	2
Eutopia VC	2
Siparex Groupe	2
Sofimac Investment Managers	2
AQUITI Gestion	2
Point Nine	2
WiSEED	2
Amundi Private Equity Funds	1
INRA	1
Inserm Transfert Initiative	1
Crédit Mutuel Innovation	1
Societe Generale Asset Management	1
Banque Populaire Group	1
Capitole Angels	1
ACG Management	1
NACO	1
ADI Nouvelle-Aquitaine	1
Banexi Ventures	1
Calao Finance	1
ACT Venture Partners	1
MACSF	1
Credit Mutuel	1
Thai Union Ventures	1
Sudinnova	1
Afone Participations	1
AxLR	1

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.

Investment focus

Software, Information Technology, Health Care
Seed, Funding Round, Series A
France, United States, Switzerland

Portfolio highlights

Vibly — Vibly is a comprehensive management and communication platform designed to support higher education associations by enhancing organizational efficiency, increasing the visibility of student initiatives, and fostering a stronger sense of belonging within educational communities. Through its secure, closed network, Vibly ensures the protection ofprivate data while facilitating seamless interaction and collaboration among students, faculty, and associations.
Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
NEBULA — NEBULA maps 3D macromolecule using dataset-free genAI and physics, enhancing drug target discovery, which forms the basis of all new drugs.

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Investment focus

Health Care, Biotechnology, Pharmaceutical
Series A, Seed, Series B
France, Switzerland, Spain

Portfolio highlights

Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
Omnidoc — Omnidoc is a tele-expertise platform for healthcare professionals to exchange medical opinions.
Raidium — Radiology augmented GPT to tackle the complexity of precision medicine

Omnes VC is the Venture Capital arm of Omnes Capital, a leading private equity firm dedicated to energy transition and innovation with €4.8 billion in assets under management and a 20 year + experience in: venture capital, buyout & growth capital, private debt, renewable energy, co-investment, secondary funds of funds. Omnes Capital is fullyindependent.With 65 business sales including 14 IPOs carried out in 16 years, Omnes VC is one of the key players in France in financing innovative SMEs with expertise in both Technology and Healthcare sectors. Omnes VC has supported 120 companies and has invested more than €500M in businesses such as Scality, Novaled, BioVex, arGEN-X, Pixium, Blablacar.

Investment focus

Biotechnology, Software, Health Care
Series A, Funding Round, Series B
France, Germany, United States

Portfolio highlights

Planet A Foods — The chocolate revolution is here. 100% cocoa-free and unbelievably delicious. We call it QOA. You need to try it!
Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
The Exploration Company — For Space & Non-Space Industries.

Seventure Partners is a French venture capital firm targeting in Tech/Digital and Life Sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with € 1 billion undermanagement as of December 31, 2023. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.The different funds/verticals on which Seventure Partners are focusing on today: - Life Sciences : Biotech, Healthcare, Nutrition - Tech/Digital : B2B SaaS, Fintech, Retailtech, Cybersecurity - Sports & Wellbeing - Blue Economy

Investment focus

Biotechnology, Health Care, Software
Series A, Series B, Funding Round
France, United States, Germany

Portfolio highlights

FIRE1 — FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
Syroco — Syroco is a Climate Tech startup that supports the energy transition of maritime transportation. It provides a solution for weather routing and voyage optimisation of commercial vessels, leveraging digital twins based on data and AI.
bsport solution — Designed to support all facets of studio management, our software allows studio owners and managers to streamline and centralise all their operations into one user-friendly platform.

Idinvest Partners is a pan-European private equity manager focused on the low and middle-market segments. With over 6 billion euros under management, the company has developed several complementary areas of expertise, including equity investments in buyout deals focusing on both mid-size as well as young innovative European companies; primaryinvestments in European private equity funds focusing primarily on the middle market segment; secondary investments; mezzanine investments in Europe; and private equity consulting.Idinvest Partners’ recent success stories include Criteo, Clear2Pay, Meetic, Prosensa, Converteam, Kwik Fit, Lastminute.com, Dailymotion, Deezer, Talend, Synthesio, Menlook, Vestiaire Collective, Pretty Simple, Curse.com, Withings, Kantox, Secret Escapes, Happn, Peakon, Dayuse, Botify, Financefox, Azalead and many more.

Investment focus

Biotechnology, Health Care, Software
Series B, Series A, Funding Round
France, United States, Spain

Portfolio highlights

Corti — Corti offers a digital assistant, augmenting medics in improving patient outcomes and internal performance.
Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
Stilla Technologies — Stilla Technologies is taking digital PCR to a whole new level with a unique 6-color target detection capability

Paca Investissement is specializes in investing in startups and developmental stages. The fund invests in the Provence-Alpes-Côte d'Azur (PACA) region.

Investment focus

Software, Internet, Manufacturing
Seed, Funding Round, Series A
France

Portfolio highlights

GANGZ — Gangz is the first digital platform for talent recruitment: Models, hosts, extras and actors.
SailEazy — The SailEazy community offers all sailing enthusiasts the choice of freedom. A shared professional fleet, bases between the Atlantic and the Mediterranean ... discover a disruptive and innovative way of navigation. Throughout the year, 7 days / 7 and 24 hours a day, you can book and discover the high-performance sailboats of a professionalfleet, entirely managed by SailEazy. Subscriber, or punctual browser, autonomous or not, you have the choice. You freely determine your niche of reservation, without constraint time or duration, you choose your base of departure and your sailboat, according to your program (short exit, cruise, regatta, coastal, wide ...). Hourly pricing includes a 360 ° service keychain beyond the cost of the lease, including insurance, fuel, cleaning and equipment. Compulsive veiled, expert or contemplative, all members of the community have their way of navigating.
C4Diagnostics — C4Diagnostics developed a fast, reliable detection of microorganisms. Our Click-chemistry technology is at the core of our portfolio of diagnostic tests.

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
France, United States, United Kingdom

Portfolio highlights

nChroma Bio — nChroma Bio's integrated product engine allows for safe, accurate, and targeted in vivo administration, addressing major shortcomings of current genetic medicine techniques.
Noema Pharma — BEYOND SYMPTOM CONTROL Developing therapies to help both orphan and larger patient populations with conditions of the brain and nervous system live their li ...
Tenpoint Therapeutics — Tenpoint Therapeutics Ltd. is a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye.

AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.

Investment focus

Biotechnology, Health Care, Pharmaceutical
Seed, Series A, Funding Round
France, Spain, Belgium

Portfolio highlights

Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
Tenpoint Therapeutics — Tenpoint Therapeutics Ltd. is a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye.
Augustine Therapeutics — Augustine, Innovative therapies for neuromuscular and neurodegenerative diseases

Karista is an early-stage venture capital firm created in 2001 investing in Health, Digital, Tech, and NewSpace.

Investment focus

Software, Biotechnology, Health Care
Seed, Series A, Series B
France, United States, Finland

Portfolio highlights

Deemea — Deemea is a collaborative AI platform that connects and provides services for the analysis of medical data for physicians. It uses its expertise in clinical research, data science, and software development to help healthcare professionals.
10Lines — 10Lines is developing autonomous parking lot marking robots and technological solutions to significantly increase productivity in the industry of pavement marking. Our solutions are helping striping businesses do their work much more productively with a smaller environmental footprint.
Brightflow — Brightflow operates as a medical device startup.

Blue Horizon is accelerating the transition to a sustainable food system that delivers outstanding returns for the planet and people.

Investment focus

Food and Beverage, Food Processing, Biotechnology
Seed, Series A, Funding Round
United States, United Kingdom, France

Portfolio highlights

WOW EARN — WOW EARN connects users to the blockchain, enabling them to mine, earn, and trade via decentralised mining, earning, and trading systems.
foodforecast — AI supported solution to reduce food waste.
New School Foods — Whole-muscle, plant-based seafood

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Seed
United States, Germany, Belgium

Portfolio highlights

Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.
Glox Therapeutics — Developing novel precision antibiotics based on protein bacteriocins, to target Gram-negative Antimicrobial Resistant (AMR) pathogens.
Asgard Therapeutics — Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biologicalproperties of professional antigen-presenting cells.

Galia Gestion is a private equity and venture capital firm. GALIA Gestion is a “management company” approved by the AMF, with majority shareholder Alliance Entreprendre.

Investment focus

Software, Manufacturing, Biotechnology
Funding Round, Series A, Seed
France, United States

Portfolio highlights

Wizaly — Wizaly's ambition is to help advertisers understand the impact of their online & offline marketing channels across all conversions, helping clients improve the ROI of their marketing budgets by up to 30%.The Wizaly platform applies its algorithmic attribution technology to provide a holistic and unbiased vision of campaigns performancestogether with actionable optimization recommendations.
Agenium — Agenium offers career perspectives in an international and tech environment. They offer this through the specific expertise of their business units. They offer solutions to the business and of the defense, industry, and space sectors.
Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.

IRDI SORIDEC Gestion is a portfolio management company that supports startups, SMEs, and ETIs in the greater South-West of France with equity capital at all stages of development.

Investment focus

Software, Biotechnology, Information Technology
Seed, Series A, Funding Round
France, Brazil, Singapore

Portfolio highlights

IsyBuy — IsyBuy is a smartphone application that allows to find restaurants and bars that have your way, consult the menu, place order, and still pay your bill directly from your cell phone, with just one click. It's the fastest, easiest, and safest way to borrow and pay. They will never have to wait to be served by a waiter, let alone beg to receivethe account or the card machine.
Keysom — Keysom is a French startup expert in the architecture of processor cores based on the RISC-V ISA. Keysom offers ad EDA tool to automatically build unique custom processors from the application code.
Materrup — Materrup produces low-carbon earth concrete for construction and urban development. Materrup construction solutions meet the requirements of future RE2020 regulations and the urgent need to reduce the carbon footprint of the construction industry.

Air Street Capital invests in AI-first companies.

Investment focus

Artificial Intelligence, Machine Learning, Biotechnology
Seed, Series A, Pre-Seed
United States, United Kingdom, Canada

Portfolio highlights

Odyssey — The next frontier of artificial intelligence: generative world models.
Profluent Bio — Profluent Bio is an AI-first protein design company that designs novel, optimal proteins that bypass existing barriers in industry.
Interloom Technologies — Interloom offers AI-driven process automation for enterprises to maximize organizational efficiency and accuracy.

Beyond Impact is your trusted Managed Service Provider (MSP), delivering tailored IT solutions like managed IT services, cybersecurity, cloud computing, IT help desk support, and data backup. Our expert team aligns your IT with business goals, providing proactive monitoring and network security. Contact us today to streamline your IT operations for a secure, agile, and future-ready business. Beyond Impact: Empowering your IT success.

Investment focus

Food and Beverage, News, Seafood
Seed, Series A, Pre-Seed
France, Canada, Singapore

Portfolio highlights

GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
Nowadays — The Nowadays nugget is made with just 7 simple, plant-based ingredients.
SEAFOOD REBOOT — Seafood Reboot's ambition is to promote worldwide best-in-class Fish substitutes from micro-algae for natural, healthy, sustainable food and to preserve marine wildlife.

The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities to accelerate the delivery of treatments, preventions, and cures to patients. It was created to solve a critical funding gap in the T1D drug and device development pipeline. Throughpartnerships with private capital, including venture capital, pharma and foundations, the T1D Fund anticipates that it will be able to attract substantially more private investment to the T1D field than occurs today. The T1D Fund will initially focus on artificial pancreas systems, metabolic control, beta cell replacement, prevention, and beta cell restoration therapies, with an exclusive priority on the best commercial opportunities. The T1D Fund will reinvest any realized gains into new investments to further its mission.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Funding Round, Series B
United States, France, Italy

Portfolio highlights

vTv Therapeutics — vTv Therapeutics, a pharmaceutical company, focuses on the discovery and development of human therapeutics to fill unmet medical needs. Its mission is to utilize its innovative technology to rapidly translate the functional modulation of human proteins into safe and effective medicines.vTv Therapeutics has a pipeline of small molecule clinicaland pre-clinical drug candidates for the treatment of a wide range of human diseases including central nervous system disorders, metabolic disorders, inflammation, and cancer. The company has built its product candidate portfolio through internal discovery and is advancing its product candidates through in-house research and development efforts. The quality and breadth of vTv's product candidate pipeline, platform technology, scientific team, and strategic collaborations have enabled it to become a fully integrated pharmaceutical company.The company's commitment to drug discovery is reflected in its medical solutions and the many exciting potential new treatment options in its pipeline. The company's major R&D activities have focused on central nervous system disorders, metabolic disorders, inflammation and oncology.vTv Therapeutics is advancing several proprietary drug candidates. The company's lead candidate, azeliragon (aka TTP488), is a novel, orally bioavailable small molecule compound that is being developed for the treatment of Alzheimer's disease. In Phase 2 clinical trial in patients with mild to moderate Alzheimer's disease, azeliragon showed a statistically significant difference of more than 3 points in ADAS-cog at 18 months compared to placebo.Azeliragon has been granted Fast Track Designation and agreement on its Phase 3 protocol has been reached with FDA via a Special Protocol Assessment (SPA). The Phase 3 study in patients with mild Alzheimer's disease was initiated in April 2015 with a clear path forward to registration with the aim to demonstrate disease modification.vTv Therapeutics is also prosecuting the clinical development of TTP399, a novel functionally liver-selective Glucokinase Activator ("GKA") for the treatment of type 2 diabetes. In a Phase 2a study, TTP399 normalized patients' HbA1c without inducing hypoglycemia, after only six weeks of treatment. A six-month Phase 2 study is ongoing.
Eledon Pharmaceuticals — Eledon Pharmaceuticals, Inc. is a clinical-stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or cellular transplantation, and for people with autoimmune and neurodegenerative disease.
Cour Pharmaceuticals Development — COUR Pharmaceuticals is developing first-in-class therapies designed to reprogram the immune system to achieve antigen-specific tolerance...

For 20 years, XAnge has been a key venture capital fund in Europe. With 70 startups in its portfolio, XAnge invests early in innovative tech companies.

Investment focus

Software, Information Technology, SaaS
Series A, Seed, Series B
France, Germany, Belgium

Portfolio highlights

TEEPTRAK — Optimise your industrial efficiency with TeepTrak. Improve your production and exceed your objectives today!
Gladia.io — 1 stop shop AI API hub for developers
SamanTree Medical — SamanTree Medical has developed the Histolog Scanner, a confocal microscopy device intended for imaging the surface of excised human tissue specimens to visualize morphological microstructures. Easy-to-read images are available immediately, providing decision-making support at the point of care.

Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.

Investment focus

Biotechnology, Health Care, Financial Services
Seed, Funding Round, Series A
United Kingdom, United States, Switzerland

Portfolio highlights

Xapien — Xapien delivers automated insight reports on companies and individuals in minutes, so you can make informed business decisions quickly and with confidence.
OneTrust — OneTrust is a provider of privacy management and marketing compliance technology that helps organizations comply with global regulations. It automates privacy impact assessments and data inventory mapping, enforces risk remediation actions, and triggers recurring audits for continuous compliance monitoring across customer, employee, and vendor datatransfers. Its web-based software can be accessed on any device and provides a single place for a private office to collaborate with business groups, vendors, and trusted advisors managing privacy risks. The result is the ability to demonstrate privacy by design and ongoing compliance with policies, data privacy laws (GDPR, BCR, Privacy Shield), and other privacy frameworks (HITECH, ISO, GAPP, APEC).The company was founded in 2016 and is headquartered in Atlanta, Georgia.
Connect Earth — Connect Earth is an environmental data company that builds the infrastructure for climate-conscious products by aggregating and standardising environmental data and making it available through developer-first toolkits. The core product is an API solution that calculates the carbon impact of spend-based financial transactions of consumers and companies.

Heartcore Capital invests in companies re-enchanting the world through technology.

Investment focus

Software, FinTech, Artificial Intelligence
Seed, Series A, Series B
Denmark, United States, Germany

Portfolio highlights

Luca — Luca's learning platform provides learning programs for primary and secondary school students. The learning platform offers pre-recorded K12 videos, gamified content and AI powered personalized study paths, covering the entire official academic curriculum and national exams prep. Luca is a VC backed startup with HQ in Madrid & MexicoCity
Barter — Barter enables decentralized applications by ensuring efficient transaction routing and optimization.
Superform Labs — THE UNIVERSAL INTERFACE FOR YIELD IS FORMING

Social Starts is a $60M+ venture capital partnership with a uniquely data-driven approach to investing in moment-of-inception and Series A financing rounds.

Investment focus

Software, Health Care, Artificial Intelligence
Seed, Series A, Funding Round
United States, Germany, United Kingdom

Portfolio highlights

Hey Jane — Get safe, effective and affordable abortion pills delivered fast to your home. Hey Jane is the first digital abortion clinic, connecting you to licensed providers in your state through telemedicine.
Mae Health — Mae is a maternal health platform that connects expectant mothers with critical resources to drive positive pregnancy outcomes.
Wayfinder Biosciences — We design RNA for next generation biomanufacturing and smart therapeutics.

WE ARE AN EARLY-STAGE INVESTOR IN ONE OF THE MOST DYNAMIC AND ESSENTIAL FIELDS OF CURRENT HUMAN ENDEAVOR WE BRING ROBUST INVESTOR MUSCLE TO EARLY-STAGE VENTURES INVESTOR A specialized and focused investor Resources Powerful industry, substance and business resources Experience Wide networks and longstanding experience Team Yet, adaptability and speed of a lean, self-financed team

Investment focus

Biotechnology, Food and Beverage, Health Care
Series A, Seed, Series B
United States, France, Denmark

Portfolio highlights

EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
Protealis — Sustainable plant proteins for Europe
Switch Bioworks — Switch Bioworks engineers symbiotic microbes to produce sustainable nitrogen fertilizer under the control of precise genetic circuits.

Advent Life Sciences is a venture team investing in life sciences businesses. The team consists of 11 professionals with extensive scientific, medical and operational experience, and a long-standing track record of entrepreneurial and investment success across the UK, Europe and the US. The Firm invests in a range of sectors within life sciences,principally in new drug discovery, enabling technologies, and med tech. Realizations in the last three years include Algeta, Avila, CN Creative, EUSA, Micromet. Current investments include Acutus, Biocartis, Cellnovo, f2G, NeRRe,

Investment focus

Biotechnology, Health Care, Medical
Series A, Funding Round, Series B
United States, United Kingdom, France

Portfolio highlights

Argá Medtech — Novel Sine Wave Technology Promises Significant Advantages Over Existing Pulsed Field Cardiac Ablation Systems
PIC Therapeutics — PIC Therapeutics is a biotechnology company focused on fundamentally changing how we treat cancer by developing a new generation of therapeutics based on the modulation of RNA translation.
Curve Therapeutics — Curve has developed an innovative screening platform that is transforming the discovery of first-in-class therapeutics. The platform allows functional screening of diverse, genetically encoded Microcycle™ libraries against a broad range of disease-associated targets that are present in their native conformation inside a mammalian cell. Curve isdeploying this platform to build a pipeline of novel cancer drugs.

Partech is a global venture capital firm with offices in San Francisco, Paris, Berlin and Dakar. Partech invests in Internet and information technology startups at seed, venture and growth stages.

Investment focus

Software, E-Commerce, SaaS
Series A, Seed, Series B
United States, France, Germany

Portfolio highlights

KoRo — KoRo is a fast-growing FoodTech startup - one of the leading brands for healthy, long-lasting and sustainable food.
Yampa — Discover yampa's autonomous AI agents and revolutionize your customer experience. Elevate your service with the most advanced AI technology.
Socium — Socium Job these are companies that recruit and offer real career opportunities to all those who share their values and wish to invest in their development.

Sylvain is a French software developer turned entrepreneur, conference organizer and angel investor.

Investment focus

Software, Financial Services, SaaS
Seed, Pre-Seed, Angel
France, United States, United Kingdom

Portfolio highlights

GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
Waldo — The codeless way to quickly build a comprehensive test suite for teams who don't compromise on speed and quality.
TOTEM — A Totem is a place of sharing and conviviality in your office. This is an opportunity for your colleagues to get to know each other better, celebrate victories and defeats together, and build a solid culture.

Investing in the deep science and technology that can propel humanity towards a radically better future.

Investment focus

Biotechnology, Artificial Intelligence, Software
Series A, Series B, Seed
United States, United Kingdom, Canada

Portfolio highlights

Notpla — We are a combination of designers and chemists, engineers and entrepreneurs. We’re hard to define because what we’re doing hasn’t been done before. We create advanced packaging solutions that disappear, naturally.
ZeroAvia — ZeroAvia is producing the world's first practical zero emission aviation powertrain, initially targeting 20-seat airplanes to start replacing dirty jet fuel in regional transport
Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.

Eutopia is a fund for consumer startups. We back founders who are rethinking the way we eat, shop, sleep and feel. We are backing 26 startups

Investment focus

Retail, E-Commerce, Food and Beverage
Seed, Series A, Funding Round
France, Belgium, Denmark

Portfolio highlights

GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
Bastille — Bastille is a brand of urban bicycles. The Astir brand is synonymous with folding bicycles. The primary quality constraint Bastille, a British designer, aims to create a folding motorcycle with standard wheels rather than the mini 16-inch wheels that are traditionally associated with folding bikes.
Nous anti-gaspi — We anti-Gapsi is the network of anti-waste food stores. This grocery store project offers producers and manufacturers the opportunity to their downgraded and unsold products at a fair price. They are a qualitative environment, they market products excluded from the usual mass distribution circuits for small defects, physical defects, contract-datenot respected, and end of series. They offer consumers a new mode of consumption that gives priority to common sense and that is at the same time smart, qualitative, and eco-responsible. In their stores, they offer you to find, in a warm atmosphere, a complete choice of food products to save waste: fruits and vegetables, fresh and frozen products, groceries, and even a small bulk section.

Siparex, France,s first multi-sectoral private equity investment company, is founded in Lyon.It was a start-up at a time when the spirit of enterprise was flagging. It emerged in one of France's regions, listed the shares of the original company one of its main vehicles on the stock market, grew internationally, and has become one of theindependent groups in its line of business in the space of 30 years.

Investment focus

Manufacturing, Software, Information Technology
Private Equity, Funding Round, Seed
France, United States, Italy

Portfolio highlights

E-Recycle — E-Recycle is an online and offline store that specializes in recycling used high-tech products such as mobile phones, tablets, and PCs.
NeoPhotonics — NeoPhotonics design and manufacture advanced hybrid photonic integrated optoelectronic devices for ultra-fast communications networks, including optical components
Monet Associes — Monet + Associes is a public relations agency.

Acteur incontournable du capital risque de proximité, SOFIMAC PARTNERS accompagne depuis maintenant plus de 30 ans les PME régionales dans le financement de leur développement à moyen / long terme. Répondant à la problématique de sous capitalisation des PME françaises, SOFIMAC PARTNERS intervient en fonds propres aux côtés des chefsd’entreprises quelle que soit leur problématique : Création, Développement, Transmission. Gérant 200 M€ d’actifs au travers de 16 fonds (FCPR, FCPI, SCR, FIP,…), notre groupe réalise ses investissements sur une grande variété de secteurs, couvrant aussi bien les activités traditionnelles que technologiques (chimie verte, éolien, chaudronnerie aéronautique, e-commerce, édition de logiciel, médecine nucléaire etc…)

Investment focus

Biotechnology, Health Care, Manufacturing
Funding Round, Seed, Series A
France, Italy, Austria

Portfolio highlights

Ultrawatt — Ultrawatt is a mission-driven startup to improve urban architecture while making a beneficial social and environmental effect.
Mob-Energy — Mob-Energy is a privately held company specializing in the development of mobile and innovative charging solutions. It designs autonomous charging robots capable of moving energy where it is needed, optimizing the site's existing infrastructure. The company was founded in 2018 and is headquartered in Villeurbanne, Auvergne-Rhône-Alpes.
Snowleader — Votre boutique en ligne (qui sent bon le reblochon) spécialiste des sports d’hiver, outdoor et street.

Floated in 1998, thanks to the local authority "Conseil Régional d’Aquitaine" and the "Caisse des dépôts", our venture, growth and LBO funds (Aquitaine Amorçage, ACI, Aqui-Invest) now benefit from the support of public and private influential shareholders and sponsors.Up to now, AQUITI GESTION has invested in more than 200operations contributing to the creation and development of about 150 companies and thousands of jobs.Currently, ACI and Aqui-Invest manage a portfolio gathering 50 companies which revenues scale from 0 € (early stage) to 30 M€.

Investment focus

Biotechnology, Software, Health Care
Funding Round, Series A, Seed
France, United States

Portfolio highlights

Dionymer — dionymer creates endless opportunities for a multitude of industries. Replacing petrochemical polymers with a circular and biodegradable alternative.
Materrup — Materrup produces low-carbon earth concrete for construction and urban development. Materrup construction solutions meet the requirements of future RE2020 regulations and the urgent need to reduce the carbon footprint of the construction industry.
ALOGIA Groupe — ALOGIA Groupe offers preventive health responses to senior people at home through care management and innovative services.

Point Nine Capital is a Berlin-based venture capital firm focused exclusively on early-stage Internet investments in areas like Software-as-a-Service (SaaS), online marketplaces, and mobile.The fund and its managers, Pawel Chudzinski and Christoph Janz have backed a number of highly successful Internet companies such as Delivery Hero, Clio,Shiftplanning, Vend, Typeform, and Zendesk from their earliest stages.

Investment focus

Software, SaaS, Internet
Seed, Series A, Series B
Germany, United States, France

Portfolio highlights

Attio — Unlock your team's true potential with Attio, the data-driven CRM for modern teams. Manage everything from sales leads through to recruitment pipelines.
Hula Earth — Biodiversity Monitoring for Nature, Agriculture, and Infrastructure
Root Global — We help companies along the agricultural supply chain get to Net Zero.

Wiseed is a crowdfunding platform that enables its users to invest in SMEs and enterprises. The platform offers investments for startups, real-estate firms, social innovation and renewable energy projects, and agriculture firms. It was founded in 2008 by Nicolas Seres and Thomas Merquiol and is based in Toulouse.

Investment focus

Software, Manufacturing, Biotechnology
Seed, Funding Round, Equity Crowdfunding
France

Portfolio highlights

Leasi — Leasi delivers a forward-thinking rental and resource management system for companies that engage in internal or external distribution of machinery. This is achieved through an ecosystem that emphasizes the excessive use of data and datasharing, with a focus on user experience. Our goal is to create a simpler, more streamlined, and more efficientworkday for industry players by leveraging the power of data and collaboration within the ecosystem to ultimately reduce emissions, increase efficiency and enhance profitability.
Vaxinano — Vaxinano is a biotechnology company specialized in preclinical and pharmaceutical development of human and veterinary vaccines and drug delivery systems. Vaxinano was created in 2016, building on 25 years of research and clinical trials on vaccines and the patented technology of Pr Didier Betbeder.
BiPER Therapeutics — BiPER Therapeutics : First-In-Class Therapeutics to Treat Cancer. Biotech company founded in 2021 to develop and commercialize novel therapeutics.

Amundi Private Equity Funds, an Amundi asset management subsidiary, specialises in private equity and unlisted infrastructure investments. Combining a wealth of expertise in all aspects of asset management built up over more than 10 years, Amundi provides both institutional and individual investors with a wide spectrum of investmentopportunities, ranging from direct fund investments in unlisted French and foreign companies to dedicated mandates and funds-of-funds for multi-management private equity and infrastructure investments. With more than 60 professionals based in Paris, Bucharest, Cairo, Casablanca, Tunis and Warsaw, Amundi Private Equity Funds assists companies at all stages of their development, the key objective being to offer fund subscribers yields in line with the best in the industry. At 31 December 2009, French and international subscribers had committed more than â‚¬3.7 billion to Amundi Private Equity Funds, making it a leading private equity player. The company owes its solid foundations to its positioning as part of a leading third-party asset management group of companies and to its membership of two international banking groups.

Investment focus

Software, E-Commerce, Biotechnology
Funding Round, Private Equity, Series A
France, India, Hungary

Portfolio highlights

Vivalto Vie — Vivalto Vie is a privately held company that operates retirement homes in the Poitou-Charentes and Pays de la Loire regions.
Airtel — Bharti Airtel Limited, commonly known as Airtel, is an Indian multinational telecommunications services company headquartered in New Delhi, India. It operates in 20 countries across South Asia, Africa, and the Channel Islands. Airtel has a GSM network in all countries in which it operates, providing 2G, 3G and 4G services depending upon the countryof operation.Airtel is the largest provider of mobile telephony and second largest provider of fixed telephony in India, and is also a provider of broadband and subscription television services. It offers its telecom services under the "airtel" brand, and is headed by Sunil Bharti Mittal. Bharti Airtel is the first Indian telecom service provider to achieve Cisco Gold certification. It also acts as a carrier for national and international long distance communication services. The company has a submarine cable landing station at Chennai, which connects the submarine cable connecting Chennai and Singapore.
Les Opticiens Mobiles — Les Opticiens Mobiles is the first national network of opticians trained to intervene everywhere : at home, at work or in nursing homes or residences for elderly, both for working people and for fragile, isolated people.Covering the whole territory, the health professionals come to visit you with all the equipment needed. Based on an ethic chart,they offer services and products tailored to all : all types of glasses (eyeglasses, sunglasses, safety googles, contact lenses, hearing protection) with fixed prices, reimbursed by social welfare.

INRA is Europe’s top agricultural research institute and the world’s number two centre for the agricultural sciences. Its scientists are working towards solutions for society’s major challenges.

Investment focus

Biopharma, Health Care, Biotechnology
Seed, Series A
France

Portfolio highlights

ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
Exeliom — Exeliom is a clinical-stage biopharmaceutical company tackling the use of commensal bacteria as drugs. Their mission is to harness the therapeutic potential of gut microbiota to enable people to lead longer and healthier lives. They are committed to developing the next generation of probiotics: innovative microbial therapies.Exeliom develops anew class of medicines called Live Biotherapeutics based on their growing understanding of the central role of the microbiota in the immune system.The company was founded in 2016 and is headquartered in Dijon, France.

Inserm Transfert Initiative is a seed stage life science vehicle currently managing about â‚¬4.2M for the financing of new biotech companies. Inserm Transfert Initiative is the new investment vehicle of INSERM in France.

Investment focus

Biotechnology, Medical, Health Care
Series A, Series B, Seed
France, Switzerland, United States

Portfolio highlights

Eyevensys — Eyevensys is a address critical unmet needs in ophthalmology by providing a much better way of delivering ophthalmic drugs that overcomes the limitations of current options, such as intravitreal injections, surgery, intravitreal implants and biodegradable formulations. All of these current options have their drawbacks, given they are invasiveprocedures. Eyevensys’ goal is not only to improve short and long term therapeutic outcomes, but also to enhance compliance, improve ocular bioavailability and tolerability.They plan to build a high value product pipeline by enabling sustained production of therapeutic proteins in the eye that will deliver improved clinical outcomes while reducing the burden of frequent intravitreal or systemic injections and other invasive procedures.
VectivBio — We Are Ironwood
Aelis Farma — Aelis Farma is a pioneer in the development of signaling specific therapeutics that target GPCRs (and more specifically the CB1 receptor which is one of the most expressed GPCRs in the brain). GPCRs are the target of most therapeutic drugs. This family of receptors has the characteristics to activate several and often opposing signaling pathways.Unfortunately, most of the drugs acting on GPCRs either block or stimulate the entire signaling activity of the receptor resulting in unwanted and sometimes unacceptable side effects.

Crédit Mutuel Innovation is the evergreen venture capital entity of Crédit Mutuel Equity (€3.5 billion in capital). We invest €1-20M in life science, digital and deeptech companies from seed to growth stages.We help bold and ambitious entrepreneurs to develop their strong growth potential with our worldwide enterprise ecosystem (our 350+portfolio companies, our abroad subsidiaries, 150+ largest global corporates and the best-in-class experts). Because it takes more than 5 years to build a Unicorn, we invest our own equity and ensure durable partnerships with visionary leaders.Today, the 350 companies in which we have invested generate a cumulative annual turnover of €50bn and create more than 250,000 jobs.

Investment focus

Software, Health Care, Biotechnology
Funding Round, Series A, Series B
France, United States, Canada

Portfolio highlights

UroMems — The device is developing an active implantable medical device based on the cutting edge technologyl in the field of embedded systems and micro-technologies for the development of its products.
Planity — Planity, a platform that allows you to book an appointment with a professional in the beauty sector in a few clicks and quickly find a hair salon, beauty institute, barber near you
Latitude — Venture Orbital Systems provides a tailor-made service for NanoSat & CubeSat operators.

SGAM AI is a leading institutional player in Alternative Investment Management. SGAM AI successfully mixes the cultures of asset management and capital markets. They are client driven and institutional, like an asset manager. Their approach of each market is entrepreneurial and financial, like an investment bank. They offer the widest coverage ofAlternative Investment classes. Their size and profitability allow long term investments and credibility. They have the ability to offer solutions, not only products. SG Group's strengths are brought to the Alternative Investment's industry. They benefit from SG Group's long term commitment in Alternative Investments. They use the processes ans resources of SGAM Group (rated M2 by Fitch).

Investment focus

Biotechnology, Software, Health Care
Series B, Funding Round, Series A
France, United States, Germany

Portfolio highlights

Augure — Improve your brand performance with Launchmetrics' leading software solutions for fashion, lifestyle and beauty brands
Force-A — FORCE-A designs, produces, and sells optical sensors for the assessment of physiological and health status of crops. It offers crop sensors for nondestructive assessment of leaf polyphenolics. The company also provides multiparameter noncontact sensors-based on leaves or fruits, and berries autofluorescence measurements. Its multiparameternoncontact sensor provides inputs for decision support systems for a range of crops, including fertilisation needs, weed infestation, crop diseases, and crop yield and quality forecast. The company was founded in 2004 and is based in Orsay, France.
METRIXWARE — Metrixware has, since 1995, been providing software maintenance & quality management solutions to CIOs and IT professionals through its System Code range of application management tools. The company provides global organizations with information, indicators and diagnostic to streamline decision making and implement best practice and compliancestandards.

Banque Populaire Group provides banking and credit services for individuals, international and corporate.

Investment focus

Manufacturing, Energy, Software
Seed, Pre-Seed, Funding Round
France

Portfolio highlights

ATAWEY — Founded in 2012 by Jean-Michel Amaré and Pierre-Jean Bonnefond, ATAWEY designs and manufactures turnkey autonomous energy solutions for isolated sites. The entrepreneurs and their teams use mature, tried and tested French technologies to offer you an innovative, reliable and sustainable product. They build on their expertise to give you more than asimple response: a solution that adapts to your uses.The teams are well aware of the importance and the challenges of a source of energy on isolated sites, ATAWEY guarantees you support and a tailor-made service. They take full responsibility for the management of each project for optimal adaptability and reliability, economic relevance with a fast return on investment, all with the greatest respect for the environment.
Quotelo — Quotelo creates an automatization system for hoteliers to regain commercial independence in the hospitality industry and digitizes group-event-seminar reservations. The company's platform centralizes all requests and reservations for groups, events, and seminars for any type of establishment by adding a graphical chatbot to each hotel'swebsite and collecting MICE and group requests from customers automatically generating commercial proposals and reserving the rooms, restaurants, activities, and nights requested, allowing hotels to book seminars, meetings, or even events online and improve productivity, responsiveness, image, and predictability.
Meccellis Biotech — Meccellis Biotech is a manufacturer of tissue and cell and biomaterials.

Capitole Angels is to create this association was born from the experience of many of its founders in the field of start-ups including the following observations. Need a structure enabling them to meet investors / promoters of the project. Plethora of potential investors hampered by the lack of an open structure. A region rich in technology,its universities, laboratories and therefore the bearer of innovation.

Investment focus

Information Technology, Software, 3D Technology
Seed, Angel, Funding Round
France

Portfolio highlights

Hoope — Hoope offers crunchy mueslis, spreads, and biscuits rich in nutrients, all organic, without palm oil, additives.
Deepbloo — DeepBloo is a Sales and Market Intelligence platform. We provide : + 5.8 millions tenders and market information Worldwide and + 300 000 tenders in France
Sensivic — Designed and manufactured in France, SENSIVIC smart audio detection systems add meaning to your security. Our solutions automatically detect and alert you in real time as soon as an abnormal sound or suspicious noise occurs.

Smalt Capital anciennement ACG Management, est un acteur majeur depuis plus de 20 ans

Investment focus

Software, Health Care, Biotechnology
Funding Round, Seed, Series A
France, Madagascar

Portfolio highlights

Kamp'n — Partenaire de croissance Facebook Ads & Google Ads
Little Cigogne — Little Cigogne is reinvents the shopping experience for children.
My Coach Football — My Coach Football allows you to manage and organize the daily operations of your football team, day after day, season after season. Designed to answer amateur and professional coaches’ needs, the platform centralizes all of your squad’s information and allows to gain time and efficiency. In a single click, you can manage players and their personalinformation, the preparation of training and games, but also individual and collective statistics. Season after season, you keep all those data and hence enjoy an optimum tracking of your team’s progression.

NACO is a co-investment fund for start-ups and small and medium-sized businesses (SMEs). NACO is a regional co-investment fund backed by Région Nouvelle-Aquitaine and managed by M/Capital Partners.

Investment focus

Health Care, Medical, Manufacturing
Seed, Series A, Funding Round
France

Portfolio highlights

inHEART — inHEART is a spin-off from IHU Liryc and Inria, two top-tier research centers respectively in cardiac electrophysiology and digital science and technology, that develops software solutions for medical image analysis and cardiac modeling in heart rhythm disorders. inHEART vision is to make the bridge between radiology and cardiology to become aworldwide leader in image-guided diagnosis, therapy planning and navigation software solutions for heart rhythm disorders.
Pony — Instant city bike hire
Touch Sensity — Touch Sensity is an information technology company that specializes in the fields of IoT and sensors.

ADI Nouvelle-Aquitaine is a non-profit organization that renders fundraising, strategy, innovation management, and support services.

Investment focus

Life Science, Biotechnology, Waste Management
Seed
France

Portfolio highlights

Dionymer — Dionymer is putting money into the circular economy by creating a method that uses microorganisms to convert industrial organic waste into biodegradable polyhydroxyalkanoates, or PHA, polymers.
Midipile Mobility — Midipile Mobility is a B2B subscription-based turnkey service for logistics professionals. They target middle mile and last mile deliveries.Their service is built on a new type of vehicle: 4 wheels, closed body, solar, 45 km/h (28 mph). It includes fleet management tools (SaaS), insurance, maintenance and assistance. Midipile is a low-carbonalternative to delivery trucks independent from the grid thanks to free solar energy and battery swapping solution.Their services offers the guarantee of better profitability combined with a unique user experience and a controlled and quantified carbon footprint.

Banexi Ventures Partners invests through venture capital funds, in early stage companies with high growth potential and high technology in 3 different sectors. The company is headquartered in Paris, France.

Investment focus

Mobile, Internet, Video
Series B, Series A, Funding Round
France, United States, United Kingdom

Portfolio highlights

Dolmen — Dolmen is an all-in-one platform to answer your many customer knowledge issues. Dolmen is the SAAS software solution to deploy in physical outlets and in your marketing departments. In local to animate, conquer and retain your customers. Central to enrich your databases and allow your network to communicate autonomously while driving your marketingactions.
Reevoo — Millions of shoppers use Reevoo to make better buying decisions in their everyday lives. Hundreds of brands all over the world use our solutions to get a better idea of what makes their customers tick.It’s our transparent and independent approach that makes the difference – we believe honest communication between brand and shopper is better forboth.Reevoo was started by Richard Anson, Ben Griffiths and Guy Logan in 2005 to help customers choose what to buy – not just where or when.Today, Reevoo is seen in more than 60 countries and in 30 different languages. We’re relied on by customers around the world to make better decisions, and by brands to connect with their customers.
Linkfluence — Linkfluence is a consumer insights platform that combines social media data, AI, and human market research expertise to uncover high-value insights..

CALAO Finance is an independent private equity company, specialized in financing European SME.

Investment focus

Information Technology, Software, Big Data
Funding Round, Series A, Series B
France, United States

Portfolio highlights

ISYBOT — ISYBOT is a designer and manufacturer of collaborative robots or "Cobots", that is to say, robots working in collaboration with workers. Its cobots work with workers and make it possible to: - reduce the arduousness of workstations - multiply their productivity - enhance manual workstations ISYBOT is based on a breakthrough technicalinnovation, resulting from 15 years of R&D carried out within CEA LIST .
Kalray — DPU processors, accelerator cards, software-defined storage and data management solutions for high-performance, data-centric computing.
ISYBOT — ISYBOT is a designer and manufacturer of collaborative robots or "Cobots", that is to say, robots working in collaboration with workers. Its cobots work with workers and make it possible to: - reduce the arduousness of workstations - multiply their productivity - enhance manual workstations ISYBOT is based on a breakthrough technicalinnovation, resulting from 15 years of R&D carried out within CEA LIST .

Early stage deep tech investor

Investment focus

Artificial Intelligence, Software, Manufacturing
Seed, Convertible Note, Series A
Turkey, United States, United Kingdom

Portfolio highlights

Nextmol — Nextmol is your partner to accelerate chemicals discovery. Reduce time-to-market and get key insights about the behavior of your chemical molecules!
Qubitrium — Explore innovative quantum solutions at Qubitrium. Elevate your journey with cutting-edge products, services, and trainings. Your quantum future...
Meddenovo Drug Design — Meddenovo is at the forefront of AI-driven drug discovery, pioneering a specialized technology platform designed specifically for cyclic peptides. Our innovative approach leverages a unique blend of AI technologies and molecular modeling to significantly enhance the efficiency and success rates of drug development processes. Cyclic peptidesrepresent a groundbreaking class of compounds in pharmaceutical research. These molecules combine the best attributes of small molecules and large biologics, offering exceptional binding affinities, stability, and specificity. At Meddenovo, we are leaders in harnessing the potential of cyclic peptides, developing tailored solutions that push the boundaries of traditional drug discovery. Beyond small organic molecules, our expertise extends to peptide-based medicines and metal chelators, giving us a competitive edge in novel drug research and development. We excel in creating unique chemical spaces tailored to your needs and provide custom computational solutions for predicting drug resistance, elucidating biochemical reaction mechanisms, and conducting metal affinity analysis. At Meddenovo, we are dedicated to precision and reliability in drug discovery. Our approach reduces failure rates and improves outcomes, accelerating the journey from research to market. Our mission is to empower scientists worldwide with advanced, user-friendly AI tools, democratizing access to cutting-edge drug discovery technologies.

Mutuelle d'Assurance du Corps de Santé Français (MACSF) is the provider of insurance to health professionals. MACSF protects and accompanies 950,000 members of all medical and paramedical specialties, offering professional and personal solutions in insurance, savings, financing, and pensions. Its products and services meet the real needs ofits members by accompanying them in the evolution of their profession and their projects.MACSF was founded in 1935.

Investment focus

Health Care, Artificial Intelligence, Medical Device
Series A, Funding Round, Seed
France, Spain, Ecuador

Portfolio highlights

Pixmania — Pixmania is an e-commerce website that provides buying and selling of speakers, cameras, headphones, and mobile devices.
Singulier — The new guard of strategy firm
RDS — RDS is a healthcare technology startup that specializes in remote patient monitoring solutions. The company's primary product, MultiSense®, is designed to help healthcare professionals continuously monitor patients' physiological parameters, whether they're in a hospital or at home. This innovative and multi-patented technology isaimed at improving patient pathways, which in turn enhances the quality of life and care efficiencies. The company's market is primarily hospitals (particularly surgical departments) and institutions that are looking for ways to improve patient care and reduce hospital stays. By facilitating early hospital discharge and continuous monitoring, RDS solution can contribute to significant healthcare savings. The MultiSense® solution is now CE marked (MDR) and is available for sale in several European countries. The company generates recurring revenues by providing the solution on a “fee for a service” business model to healthcare institutions and professionals. The product has been well-received in the market, earning multiple awards and the support of a vibrant community of clinicians. In addition to its primary product, RDS also provides services that help healthcare systems become more attractive and sustainable. This includes training and support for healthcare professionals to effectively use the MultiSense® technology. Keywords: Healthcare Technology, Remote Patient Monitoring, MultiSense®, Patient Pathways, Care Efficiencies, Hospital Discharge, Healthcare Savings, Clinicians, Physiological Parameters, Our main product, MultiSense®, is a comprehensive Remote Patient Monitoring Solution. MultiSense® offers healthcare professionals a high-precision, multi-parametric solution to continuously monitor patients’ physiological parameters in the hospital and beyond. MultiSense® combines a wearable patient monitor designed to capture high-accuracy physiological data with a cloud platform that helps transform these data into actionable clinical insights. MultiSense® is a patented medical device that has received multiple awards. MultiSense® has been validated by 6 completed clinical investigations.RDS relies on a talented and international team with deep subject-matter-expertise and a proven track record in the Healthcare and Medical Device sector. At RDS, we all share the same passion for bringing patient pathways to the next level.

Credit Mutuel is a French investment bank specialized in early stage venture investments.

Investment focus

Finance, Financial Services, E-Commerce
Funding Round, Series A, Seed
France

Portfolio highlights

Hipli — Hipli is a reusable, eco-friendly packaging solution that offers a sustainable alternative to plastic packaging for e-commerce businesses.
Vinidaily — Vinidaily is the application that helps you choose the wine 100% adapted to your tastes and the occasion, in your favorite supermarket and soon everywhere else.
Agrilife Studio — Agrilife Studio is a startup studio focuses on agriculture and environment.

Thai Union Ventures is a corporate venture arm of thai union group.

Investment focus

Life Science, Biotechnology, Food Processing
Series A
France

Portfolio highlights

Algama — Algama harvests the potential of algae to create food that's good for both people and the planet.

Sudinnova is a venture capital firm that invests in information technology, electronics, life sciences, and clean technology sectors.

Investment focus

Software, Biotechnology, Medical
Funding Round, Series A, Seed
France

Portfolio highlights

Kerlink — Founded in 2004, Kerlink is a fast-growing, global and publicly traded provider of Internet of Things (IoT) infrastructure, software and services serving telecom operators, public authorities and businesses of all sizes to design, launch and operate IoT networks.Anticipating a booming market for communication solutions dedicated to connecteddevices, Kerlink founders – William Gouesbet, chairman and CEO, and Yannick Delibie, deputy CEO and CTIO – foresaw the role that RF communication technologies and their associated support platforms could play in M2M vertical segments like fleet management, metering and freight.A co-founder and board member of the LoRa Alliance, Kerlink specialises in end-to-end IoT network solutions for LoRaWAN cost-effective, energy-efficient and long-distance connectivity. The company designed the world’s first commercially available product range of outdoor carrier-grade for IoT dedicated networks.Kerlink also has continuously launched a range of embedded & ruggedized devices and applications for transportation using cellular connectivity, in addition to fleet management and tracking solutions, such as passenger information and entertainment, fuel-efficiency monitoring and car/bike sharing.
Lucibel — Lucibel is an innovative French group that designs and manufactures new-generation lighting products and solutions in France based on LED technology. LED technology is cost efficient, sustainable and smart. It is transforming the world and is now part of the digital era. Not only are Lucibel lighting solutions compatible with remote managementsystems. Light can now interact with its surroundings and be controlled and measured in real time. But it also allows for a new medium for data transmission, interactions and well-being thanks to the development by Lucibel of innovative and smart solutions.
Universign — Have your PDF documents signed online with Universign: the electronic signature and timestamping service recognised by Adobe Reader.

Afone Participations is a telecommunications and electronic payments company.

Investment focus

Software, Compliance, Life Science
Series A
France

Portfolio highlights

BMI System — BMI System is a management software editor for the pharmaceutical, medical, and cosmetics industries The company exports its software packages to Europe and America. With the NAYA Compliance application it has established itself as the leading French company for regulatory compliance software for the pharmaceutical industry.

AxLR specializes in the assistance of commercialization and academic research maturity-based innovative projects.

Investment focus

Life Science, Biotechnology
Pre-Seed
France

Portfolio highlights

Ingraalys — Ingraalys studies genomic and cellular plasticity during development and aging. Exploring the limitations of this plasticity prompted her to investigate the potential reversibility of cellular aging.